News and Announcements
Aviator Capital is pleased to announce the launch of the Harbourview Fund in Darwin
- Published August 11, 2022 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Harbour View Plaza is a landmark Darwin City office building that has a strong track record of occupancy accommodating a mixture of NT Government and Federal Government tenants. NT Government lease expiry is out to 2033. The building is currently 100% leased. Significant capital expenditure upgrading the property and its facilities has further enhanced the quality of the asset and provides Aviator’s investors with a lower risk secure long-term investment.
Darwin is central to the Northern Territory’s diversified economy, which is expected to grow by 53%, in terms of Gross State Product (GSP), by 2030. The Territory is experiencing significant investment totalling approximately $29.9Bin current projects.
(Northern Territory Government, 2022)
The key investment highlights of the property at 8 McMinn Street Darwin are:
| Site Area | 5,330 m2 |
| Gross Lettable Area | 5,775.4 m2 over 6 levels |
| Car Parking | 155 undercover and on-grade car parks |
| Sustainability (NABERS) | 5.5 Star |
| Fully Leased Gross Income | $2,471,065 (Estimated) |
| Estimated Outgoings | $501,728 |
| Fully Leased Net Income | $1,969,337 (Estimated) |
| WALE | 7.7 years (by area) at 30 June 2022 |
| CAPEX | $5.9m spent on major works |
This is an exciting opportunity in invest in the Darwin CBD with distributions from the Fund commencing at 8.5% per annum paid monthly.
Aviator Capital looks forward to welcoming you as an investor in the Aviator Harbourview Fund.
Company Updates
The System’s Immune System: Why Big Tech Will Solve What Big Pharma Can’t
The central investment thesis for the future of human health pits Big Pharma against Big Tech. This blog post explores the “Protocol Paradox” in current cancer care and argues that the convergence of hyperscalers and life-science experts—treating biology as a data and compute problem—represents the defining compounding investment opportunity of this era.
The Life Sciences Supercycle: Why Australian Biotech is Finally Delivering Billion-Dollar Outcomes
Australia’s life sciences sector is experiencing an unprecedented “Supercycle,” finally commercializing world-class research into global, billion-dollar businesses. Learn about the ASX heavyweights, the key drivers (AI, institutional execution, FDA pathway), and the investment opportunity at Emergence 2026.
Following the Billions: Where the Hyperscalers are Betting on the Future
The roadmap for the next decade isn’t hidden in pitch decks—it’s written on the balance sheets of Microsoft, Amazon, and Google. Their collective investment is flowing into three key areas: GPU Chips, AI Factories, and Energy. This foundational buildout signals a $7–$20 trillion economic convergence, where the physical race for infrastructure and energy is paramount. The article also covers the powerful macro case for digital assets in this new era.
Backed By Leading Investment Groups and Family Offices
